The discovery of recombinant DNA proved that biology, not chemistry alone, could create new medicines like life-saving ...

The companion animal vaccines products market is expected to reach USD 3,964.7 million by 2025 and is expected to steadily grow at a CAGR of 4.2% to reach USD 5,982.7 million by 2035. In 2024, ...

Whippany: Bayer announced that the U.S. Food and Drug Administration (FDA) has approved Jivi, a recombinant DNA-derived, ...

The proteinase k market is expected to reach approximately USD 30.2 million in 2025 and expand to around USD 48.2 million by 2035, reflecting a compound annual growth rate (CAGR) of 4.8% over the ...

Bayer (BAYRY) announced that the U.S. Food and Drug Administration has approved Jivi, a recombinant DNA-derived, extended half-life factor VIII concentrate, for use in pediatric patients 7 years of ...

One of the greatest transformations in modern medicine arguably began with a corned beef sandwich.It was the late 1960s, and ...

Not intended for media outside the U.S. WHIPPANY, N.J., May 19, 2025--(BUSINESS WIRE)--Bayer announced that the U.S. Food and Drug Administration (FDA) has approved Jivi ®, a recombinant DNA-derived, ...

A new study published in Physical Review Letters has introduced a new form of the classic Ising model that, by incorporating ...

Jivi first received FDA approval in August 2018. The approval was for use in previously treated adults aged 12 and older who have hemophilia A. The uses included on-demand treatment and control of ...

I traveled to the iconic Asilomar Conference Grounds in Monterey Bay as one of 50 “Next Generation Leaders” invited to take ...

HHS Secretary Robert F. Kennedy Jr.'s probe into mifepristone was fueled by a flawed analysis of insurance claims from a ...

Discover how hemophilia A affects blood clotting, its genetic patterns, warning signs, advanced treatment options, and ...